Experts review the diagnosis, prognosis, and management of hepatorenal syndrome–acute kidney injury (HRS-AKI). Topics include the role of biomarkers in the diagnosis of HRS-AKI, and pharmacologic and nonpharmacologic treatment options in liver transplant candidates.